Price To Earnings Ratio -271.41 | Sector PE 69.55 |
PB Ratio 3.07 | Sector PB 8.96 |
EPS -3.83 | Dividend Yield 1.79 |
Today's Volume 117.689 K | 5 Day Avg. Volume 324.772 K |
PEG Ratio 2.37 | Market Cap. ₹ 17,650.00 Cr. |
Jubilant Pharmova Limited is an India-primarily based totally incorporated pharmaceutical company. The Company's segments encompass Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals phase, via absolutely owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and deliver of energetic pharmaceutical ingredients (APIs), strong dosage formulations, radiopharmaceuticals, hypersensitive reaction remedy merchandise and agreement production of sterile injectables and non-sterile merchandise via six production centers in India, United States and Canada and a community of about forty eight radio pharmacies withinside the United States. The Contract Research and Development Services phase affords drug discovery and improvement offerings in addition to medical records software program and carrier solutions. The Proprietary Novel Drugs phase is a patient-targeted biopharmaceutical enterprise operating to cope with unmet scientific wishes in oncology and autoimmune diseases.